2015 Turkish Pharma Growth Driven Mainly By Volume
This article was originally published in PharmAsia News
Executive Summary
New data show the total Turkish pharmaceutical market was valued at some $5.7bn in 2015, a growth of around 15% over the previous year. Analysis shows that the increase came mainly from volume while price increases contributed relatively little, suggesting that despite increasing consumption, government price controls are working. However, overall market growth still exceeded official expectations.